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nection between the right AV ring and the apex of the RV was present, bypassing the AV-
node. There was lack of expression in the RV inflow tract, which may be in accordance
with the secondary addition of myocardium to this area.
Conclusion: Lac Z reporter gene expression is able to delineate the developing murine
cardiac conduction system. Next to the CCS-lacZ expression in the right and left AV ring,
expression was observed in the right ventricular moderator band, which was connected
to the right AV ring. These findings may implicate a developmental morphological sub-
strate for WPW-syndrome and Mahaim tachycardias.
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1001-18 Determinants of Natural Regression of Pulmonary Vein 
Stenosis Secondary to Radiofrequency Catheter 
Ablation for Atrial Fibrillation
Yong-Mei Cha, samuel J. Asirvathom, Thomas M. Munger, Paul A. Friedman, Luiz Leite, 
Laura Peterson, Christie Bluhm, Douglas L. Packer, Mayo Clinic, Rochester, MN
Background: Pulmonary vein (PV) stenosis following radiofrequency ablation (RFA) for
the treatment of trigger-mediated atrial fibrillation (AF) may undergo spontaneous regres-
sion in some cases. The conditions favoring this change are unclear however. Methods:
Therefore, the determinants of spontaneous reversal of RFA-mediated PV stenosis was
studied in 203 consecutive patients (pts) who underwent ablation of 525 PVs for drug-
refractory paroxysmal AF. Three-dimensional reconstructions of 8 or 16 row spiral CT
images were utilized to measure the narrowest, cross-sectional diameter of the PVs at
baseline (B), 3-month (3M) and >6-month (6M) after RFA. Results: Moderate PV stenosis
(>50%) developed in 11 pts (17 PVs) following the ablation. Significant reduction of PV
stenosis was observed in 4 pts. (6 PVs) at >6-months of follow-up (group 1: 15±2mm at
B; 6±1mm at 3M; 9±2mm at 6M; p<0.05). In contrast, the severity of PV stenosis
remained unchanged or worsened in the other pts (group 2: 12±2mm at B; 4±2mm at
3M; 2±1mm at 6M). Univariate analysis revealed predictors of spontaneous reduction of
PV stenosis as shown in the table. The baseline PV size was the most important predic-
tor, while age, AF duration, number of RF delivery, duration and temperature of RFA were
not predictive of outcome. Conclusion: Despite >50% narrowing after RFA, spontaneous
remodeling occurs in the PVs with largest baseline diameter. Ablation duration and tem-
perature are less important determinants of the long term outcome of PV stenosis.
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Fibrillation: Trigger Isolation Alone or Supplementary 
Left Atrial Substrate Modification?
Dipen Shah, Haran Burri, Henri Sunthorn, Ulrich Sigwart, Hopital Cantonal Universitaire 
de Geneve, Geneva, Switzerland
Background
Selecting the minimum effective intervention for curative ablation of atrial fibrillation (AF)
may reduce side effects. We evaluated pulmonary vein (PV) trigger isolation vs supple-
mentary left atrial (LA) substrate modification in a consecutive cohort of patients with AF.
Methods
58 patients (45M,13 F; age 55 ± 9 yrs; 4 with structural heart disease) underwent cura-
tive catheter ablation for drug resistant, symptomatic paroxysmal(n=42) or persistent
AF(n=16). Irrigated tip RF ablation was used to perform circular mapping guided electro-
gram demarcated isolation of all PVs (35 W limit), cavotricuspid isthmus ablation and lin-
ear LA ablation (50W limit) guided and validated by Biosense 3D mapping.
Results
Successful isolation of all PVs (n=230) was performed in all patients. Cavotricuspid isth-
mus block was created in 32 patients with typical atrial flutter and linear LA ablation per-
formed in 14 patients with either persistent AF (n= 10) or recurrent AF despite successful
PV isolation (n= 4). Linear ablation from the left PV ostia to the mitral annulus was per-
formed in 14 (complete block in 11), and across the posterior LA from the right to left
ostia in 7 (block in 3). 1.4 procedures per patient (187± 51min, RF time 39 ± 14min) were
performed: (1.2 procedures per paroxysmal AF patient). One reversible ischemic neuro-
logic deficit and one tamponade occurred. After a follow up of 9 ± 5 months, with 6
patients on antiarrhythmic drugs (AAD), 1 patient has persistent LA flutter and 2 have
paroxysmal AF, so that 95% (40/42) with paroxysmal AF and 72% (12/16) with persistent
AF are in stable sinus rhythm without AAD.
Conclusion
Electrogram demarcated circular mapping guided isolation of all PVs (often supple-
mented by cavotricuspid isthmus ablation) results in excellent drug free success rates in
patients with paroxysmal AF without requiring additional LA linear ablation. High success
rates may be achieved in patients with persistent AF when PV isolation is supplemented
by electrophysiologically validated linear LA ablation.
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1001-20 Investigation of Coronary Venous Anatomy by 
Multislice Computed Tomography
Jing Ping Sun, Neil J. Greenberg, Bruce L. Wilkoff, Craig R. Asher, Richard D. White, 
James D. Thomas, Mario J. Garcia, The Cleveland Clinic Foundation, Cleveland, OH
Background: The coronary venous system is increasingly being targeted for left ventric-
ular or biventricular pacing in patients with severe heart failure. The present study investi-
gated the appearance of the coronary sinus and its tributary veins as visualized on multi
slice computed tomography (MSCT) in patients with coronary artery disease (32), chest
pain (9), valvular disease (5) and hypertrophic cardiomyopathy (2).
Methods and Results: Forty-eight patients (60±10 years old, 38 males) were scanned
using a retrospectively ECG-tagged cardiac protocol on a 16-slice CT scanner. The scan
was initiated following intravenous contrast agent administration and enhancement of the
aorta. The entire heart was imaged within a single breath-hold. CT scan parameters
included: 140 kVp, 400 mAs, 0.8 mm slice thickness, 0.4 mm slice increment, 0.42 sec
rotation time, 0.2 - 0.3 pitch. The appearance of coronary venous segments was evalu-
ated using volume renderings in three-dimension space. The diameter, length, and angu-
lation of coronary veins were measured from curved multi-planar reformatted images
following vessel centerline extraction. The characteristics of coronary veins are listed in
the table. 
Conclusions: This study shows the appearance, diameter, length, and angulation of cor-
onary veins can be determined using MSCT. This capability should be useful for pre-
operative lead placement planning in the coronary venous system.
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1001-21 Inhibition of ERK/p38 MAP-kinase and Calcineurin-
NFAT Hypertrophy Signaling by Inducible 
Hemoxygenase-1 in Cardiac Myocytes
Joern Tongers, Beate Fiedler, Tibor Kempf, Theresia Kraft, Stepan Gambaryan, Suzanne 
M. Lohmann, Kai C. Wollert, Hannover Medical School, Hannover, Germany, University 
of Würzburg, Würzburg, Germany
Inducible hemoxygenase-1 (HO-1) is the rate-limiting enzyme of heme degradation, and
promotes the formation of carbon monoxide (CO), free iron, and biliverdin (BV), which is
continuously converted to bilirubin (BR) by biliverdin reductase. HO-1 has previously
been shown to protect cardiac myocytes (CM) from ischemia/reperfusion injury. We pos-
tulated that HO-1 and its reaction products may, in addition, promote anti-hypertrophic
effects in CM. Endothelin-1 (ET-1, 30nmol/L) promoted increases in cell size (planime-
try), sarcomere organization (confocal laser microscopy), and ANP expression (Northern
blot) in ventricular CM isolated from 1-3 day-old rats. Adenoviral overexpression of HO-1
(Ad.HO–1), but not LacZ (not shown), significantly reduced this hypertrophic response.
The effects of Ad.HO-1 were mimicked by the CO-donor [Ru(CO)3Cl2]2, BV, and BR
(5µmol/L, each), suggesting that CO and BV/BR both contribute to the antihypertrophic
effects of HO-1 (Table). As shown by immunoblotting using phospho-specific anti-MAP-
kinase antibodies, CO and BV/BR suppressed the activation of ERK1/2 and p38 by ET-1.
As revealed by NFAT-luciferase reporter assays, CO and BV/BR also inhibited the cal-
cineurin-NFAT signaling pathway in ET-1 stimulated CM. In conclusion, HO-1, via forma-
tion of CO and BV/BR, promotes anti-hypertrophic effects in CM that are mediated, at
least in part, via inhibition of ERK/p38 MAP-kinases and the calcineurin-NFAT signaling
pathway.
Chi-Square P value Odds Ratio Confidence Interval
Age 0.06 0.80 0.99 0.91-1.08
AF duration 0.36 0.55 0.93 0.74-1.10
Baseline PV diameter 3.89 0.04 2.24 1.01-4.98
Number of RF delivery 2.49 0.11 0.90 0.79-1.03
Duration of RFA 2.04 0.15 0.96 0.91-1.02
RFA temprature 0.07 0.79 0.96 0.71-1.29
Coronary 
Sinus
Middle
Middle
Posterior Lateral Anterior Posterior-
lateral
Anteriot
-lateral
Ostial 
Diameter 
(mm)
9.3±2.7 4.6±1 3.6±0.7 3.0±0.8 3.7±0.6 3.2 ±1.2 2.5±0.9
Length (mm) 110±22 51±22 42±26 34±24 49±16 40±35 25±15
Take-off 
angle
77±21 94±29 113±22 123±27 112±20 90±38
Appearance 
(%)
100 90 75 70 70 30 20
Mean ± SEM, *p<0.05 vs. ET-1, n=3-8 experiments
Contr
ol
ET-1 ET-1 + 
Ad.HO-1
ET-1 + 
CO
ET-1 + 
BV
ET-1 + 
BR
Cell size 100 175 ± 
18
113 ± 8 138 ± 
12*
135 ± 9* 134 ± 9*
Sarcomere 
organization
100 160 ± 7 n.d. 122 ± 7* 127 ± 7* n.d.
ANP mRNA 100 698 
± 173
308 ± 86* 323 
± 100*
192 ± 
51*
232 ± 
55*
